Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Shree Ganesh Remedies Ltd (SGRL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: SGRL Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price
₹518.75 12.35 (2.44%)
As on 24-Aug'26 16:59
Shree Ganesh Remedies Ltd (SGRL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: SGRL Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price
₹518.75 12.35 (2.44%)
As on 24-Aug'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹666 Cr.
Current Price
₹518.8
52-Week Low / High
₹381 / 759
TTM EPS
₹12
TTM Sales
₹99 Cr.
Book Value per Share
₹127.9
P/E Ratio
43.11
Higher than its 5-year historical median
Industry PE
53.2
Price to Book (P/B)
4.06
Lower than its 5-year historical median
Price to Sales (P/S)
6.73
In line with its 5-year historical median
EV/EBITDA
19.87
In line with its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
11.53%
Outperforms industry median
Return on Capital Employed (ROCE)
14.62%
Outperforms industry median
Return on Assets (ROA)
8.61%
Operating Profit Margin
36.1%
Net Profit Margin
16.26%
Gross Profit Margin
31.2%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-13.74%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-10.69%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-23.07%
Asset Quality
Promoter Holding
72.84%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹151 Cr.
Equity
₹12.8 Cr.
Face Value
₹10
All Time Low / High
₹22.07 / 950.05
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Weak
Is Shree Ganesh Remedies Ltd a good quality company?
Shree Ganesh Remedies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Shree Ganesh Remedies Ltd performance compare with that of its Peers?
Revenue growth of Shree Ganesh Remedies Ltd vs industry peers?
Shree Ganesh Remedies Ltd revenue CAGR is 13.20%, compared to the industry median CAGR of 5.79%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Shree Ganesh Remedies Ltd?
Promoters hold 72.84% of the Shree Ganesh Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Shree Ganesh Remedies Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 11.89% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shree Ganesh Remedies Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 12.4% | 26.2% | 27.7% | 27% | 32.6% | 27.5% | 32.5% | 22.5% | 27.8% | 19.5% | - |
| Value Creation Index ⓘ | -0.1 | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 1.3 | 0.6 | 1.0 | 0.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 15.5 | 19.9 | 27.3 | 35.3 | 58.4 | 49.1 | 71.3 | 91.4 | 126 | 109 | 99 |
| Sales YoY Gr. | - | 28% | 37.3% | 29.5% | 65.5% | -16% | 45.3% | 28.2% | 37.8% | -13.7% | - |
| Adj EPS ⓘ | 1.1 | 2.8 | 3 | 4.7 | 6.7 | 7.5 | 9.6 | 12.4 | 19.5 | 17 | 12 |
| YoY Gr. | - | 167.9% | 5.6% | 57.7% | 41.9% | 11.9% | 27.3% | 29.9% | 56.6% | -12.4% | - |
| BVPS (₹) ⓘ | 15.7 | 18.6 | 23.7 | 28 | 34.8 | 41.4 | 50.9 | 69.7 | 95.1 | 113.1 | 127.9 |
| Adj Net Profit ⓘ | 1 | 2.5 | 3.6 | 5.7 | 8.1 | 9.1 | 11.6 | 16 | 26.6 | 21.9 | 15 |
| Cash Flow from Ops. ⓘ | 0 | 0 | -0.9 | -5.2 | 3.9 | 3.3 | 13.4 | 17.1 | 30.5 | 30.7 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | -2.6 | -0.1 | 0.6 | 0.1 | 0 | 1.9 | 1.2 | 1.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 24.1% | 13.2% | 15.1% | -13.7% | ||||
| Adj EPS ⓘ | 36.2% | 20.5% | 21.3% | -12.4% | ||||
| BVPSⓘ | 24.5% | 26.6% | 30.5% | 19% | ||||
| Share Price | - | 11.8% | 6.6% | -12.2% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 7 | 16.6 | 16.1 | 18.3 | 21.4 | 19.7 | 20.7 | 21.5 | 25.4 | 16.4 | 10 |
| Op. Profit Mgn % ⓘ | 12.5 | 20.5 | 19 | 24.8 | 18.7 | 27.8 | 25.2 | 26.9 | 33.2 | 36.1 | 31.4 |
| Net Profit Mgn % ⓘ | 6.1 | 12.7 | 13.3 | 16.2 | 13.9 | 18.5 | 16.2 | 17.5 | 21.1 | 20.2 | 15.6 |
| Debt to Equity ⓘ | 0 | 0 | 0.1 | 0 | 0.1 | 0 | 0 | 0.4 | 0.3 | 0.3 | - |
| Working Cap Days ⓘ | 234 | 223 | 207 | 200 | 153 | 224 | 194 | 197 | 164 | 209 | 121 |
| Cash Conv. Cycle ⓘ | 164 | 134 | 97 | 96 | 88 | 125 | 93 | 90 | 83 | 113 | 91 |
Valuation of Shree Ganesh Remed. - Standalone
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 27 | 35 | 58 | 49 | 71 | 91 | 126 | 109 | 109 |
| Operating Expenses ⓘ + | 16 | 22 | 27 | 47 | 35 | 53 | 68 | 84 | 69 | 74 |
| Operating Profit ⓘ | 4 | 5 | 9 | 11 | 14 | 18 | 23 | 42 | 39 | 35 |
| Operating Profit Margin (%) | 20.5% | 19.0% | 24.8% | 18.7% | 27.8% | 25.1% | 25.7% | 33.2% | 36.1% | 32.0% |
| Other Income ⓘ + | 0 | 2 | 1 | 4 | 2 | 4 | 1 | 3 | 4 | 3 |
| Interest ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 4 |
| Depreciation ⓘ | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 6 | 10 | 10 |
| Profit Before Tax ⓘ | 4 | 6 | 9 | 13 | 13 | 18 | 20 | 38 | 31 | 24 |
| Tax ⓘ | 1 | 2 | 2 | 3 | 3 | 5 | 5 | 10 | 8 | 6 |
| Profit After Tax | 3 | 5 | 6 | 10 | 10 | 13 | 15 | 28 | 23 | 18 |
| PAT Margin (%) | 13.3% | 17.2% | 17.7% | 16.5% | 19.9% | 18.8% | 16.6% | 22.3% | 21.3% | 16.3% |
| Adjusted EPS (₹) | 3.0 | 3.9 | 5.2 | 8.0 | 8.1 | 11.1 | 12.1 | 21.9 | 18.0 | 13.8 |
| Dividend Payout Ratio (%) | 0% | 19.10% | 18% | 14% | 18% | 4.50% | 4.10% | 0% | 0% | 0% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 16 | 29 | 34 | 42 | 50 | 62 | 87 | 122 | 145 | 163 | |
| Debt + | 0 | 2 | 1 | 2 | 0 | 0 | 32 | 30 | 29 | 21 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 2 | 2 | 4 | 4 | 6 | 9 | 15 | 8 | 6 | 9 | |
| Others Liabilities ⓘ | 2 | 3 | 3 | 4 | 4 | 6 | 8 | 18 | 19 | 19 | |
| Total Liabilities ⓘ | 21 | 36 | 41 | 52 | 61 | 77 | 143 | 178 | 200 | 213 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 4 | 6 | 14 | 16 | 19 | 27 | 58 | 81 | 95 | 105 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 2 | 3 | 15 | 17 | 9 | 13 | |
| Investments ⓘ | 0 | 4 | 4 | 7 | 3 | 0 | 0 | 5 | 18 | 13 | |
| Inventories | 3 | 4 | 7 | 6 | 13 | 14 | 18 | 25 | 22 | 24 | |
| Trade Receivables | 7 | 6 | 10 | 17 | 13 | 18 | 28 | 20 | 22 | 33 | |
| Cash Equivalents | 3 | 9 | 1 | 2 | 3 | 4 | 12 | 16 | 10 | 13 | |
| Others Assets ⓘ | 4 | 7 | 6 | 5 | 7 | 11 | 12 | 14 | 24 | 13 | |
| Total Assets ⓘ | 21 | 36 | 41 | 52 | 61 | 77 | 143 | 178 | 200 | 213 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | -1 | -5 | 4 | 3 | 13 | 17 | 30 | 31 | 24 |
| Cash Flow From Investing Activity ⓘ + | 0 | -3 | -0 | -3 | -1 | -12 | -51 | -33 | -36 | -10 |
| Cash Flow From Financing Activity ⓘ + | 0 | 8 | -0 | -0 | -1 | -1 | 39 | 10 | -1 | -12 |
| Net Cash Flow ⓘ | 0 | 4 | -5 | 1 | 2 | 0 | 5 | 7 | -6 | 2 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 17.31 | 20.75 | 19.95 | 25.35 | 21.18 | 24.02 | 20.41 | 26.87 | 17.28 | 11.53 |
| ROCE (%) | 26.15 | 27.68 | 27.04 | 32.63 | 27.51 | 32.47 | 22.46 | 27.83 | 19.53 | 14.62 |
| Asset Turnover Ratio | 1.08 | 0.96 | 0.92 | 1.25 | 0.87 | 1.04 | 0.84 | 0.81 | 0.59 | 0.54 |
| PAT to CFO Conversion(x) | 0 | -0.2 | -0.83 | 0.4 | 0.3 | 1 | 1.13 | 1.07 | 1.35 | 1.33 |
| Working Capital Days | ||||||||||
| Receivable Days | 119.60 | 87.50 | 79.80 | 82.30 | 111.40 | 81.20 | 91.90 | 68.40 | 69.80 | 90.50 |
| Inventory Days | 54.20 | 47.70 | 55.70 | 37.50 | 67.70 | 67.50 | 62.90 | 60.90 | 77 | 76 |
| Payable Days | 58.40 | 52 | 56 | 39.80 | 83.40 | 77.30 | 96.50 | 75.10 | 72 | 67.20 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Shree Ganesh Remedies Ltd FAQs
The current trading price of Shree Ganesh Remed. on 24-Aug-2026 16:59 is ₹518.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Aug-2026 the market cap of Shree Ganesh Remed. stood at ₹666.0 Cr
The latest P/E ratio of Shree Ganesh Remed. as of 23-Aug-2026 is 43.11.
The latest P/B ratio of Shree Ganesh Remed. as of 23-Aug-2026 is 4.06.
The 52-week high of Shree Ganesh Remed. is ₹759.0 and the 52-week low is ₹381.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shree Ganesh Remed. is ₹98.98 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Shree Ganesh Remedies Ltd is a average quality company.
The key valuation ratios of Shree Ganesh Remedies Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shree Ganesh Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Shree Ganesh Remedies Ltd
No data to display
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
